Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 2
1995 1
1996 1
1997 5
1998 9
1999 57
2000 71
2001 147
2002 209
2003 241
2004 305
2005 388
2006 480
2007 528
2008 554
2009 554
2010 588
2011 610
2012 640
2013 615
2014 615
2015 618
2016 614
2017 615
2018 576
2019 531
2020 539
2021 504
2022 416
2023 306
2024 279
2025 274
2026 44

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10,361 results

Results by year

Filters applied: . Clear all
Page 1
Etanercept biosimilar SB-4.
Pelechas E, Drosos AA. Pelechas E, et al. Expert Opin Biol Ther. 2019 Mar;19(3):173-179. doi: 10.1080/14712598.2019.1566456. Epub 2019 Jan 11. Expert Opin Biol Ther. 2019. PMID: 30616405 Review.
Biosimilars are highly similar molecules to other biological medicines that have already been authorized for use. Etanercept (ETN) was the first anti-tumor necrosis factor inhibitor (TNFi) approved by the Food and Drug Administration for the treatment of moderate to severe …
Biosimilars are highly similar molecules to other biological medicines that have already been authorized for use. Etanercept (ETN) wa …
GP2015: An Etanercept Biosimilar.
Deeks ED. Deeks ED. BioDrugs. 2017 Dec;31(6):555-558. doi: 10.1007/s40259-017-0246-1. BioDrugs. 2017. PMID: 28940172 Free PMC article. Review.
GP2015 is the second biosimilar of the reference p75 TNF receptor-Fc fusion protein etanercept. It is approved for use in all indications for which reference etanercept is approved, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, …
GP2015 is the second biosimilar of the reference p75 TNF receptor-Fc fusion protein etanercept. It is approved for use in all indicat …
Etanercept for treating axial spondyloarthritis.
Guillot X, Prati C, Sondag M, Wendling D. Guillot X, et al. Expert Opin Biol Ther. 2017 Sep;17(9):1173-1181. doi: 10.1080/14712598.2017.1347156. Epub 2017 Jul 6. Expert Opin Biol Ther. 2017. PMID: 28682112
In this context, TNF blockers have been a major therapeutic advance. Etanercept is a soluble recombinant TNF receptor fusion protein in this vain. Areas covered: The aim of this review is to summarize the current published data concerning the efficacy and tolerance of e …
In this context, TNF blockers have been a major therapeutic advance. Etanercept is a soluble recombinant TNF receptor fusion protein …
Etanercept for the treatment of rheumatoid arthritis.
Zhao S, Mysler E, Moots RJ. Zhao S, et al. Immunotherapy. 2018 Mar 1;10(6):433-445. doi: 10.2217/imt-2017-0155. Epub 2018 Feb 27. Immunotherapy. 2018. PMID: 29482402 Review.
Etanercept was the first specific anticytokine therapy approved for the treatment of rheumatoid arthritis (RA). ...It is structurally distinct from other TNF inhibitors and thus has desirable profiles for immunogenicity, drug survival and infection rate. With the increasin …
Etanercept was the first specific anticytokine therapy approved for the treatment of rheumatoid arthritis (RA). ...It is structurally …
Etanercept.
Ducharme E, Weinberg JM. Ducharme E, et al. Expert Opin Biol Ther. 2008 Apr;8(4):491-502. doi: 10.1517/14712598.8.4.491. Expert Opin Biol Ther. 2008. PMID: 18352852 Review.
METHODS: A search of Medline for relevant articles on etanercept and psoriasis. RESULTS/CONCLUSION: Etanercept has demonstrated efficacy in the treatment of skin and joint manifestations of psoriatic disease, thus gaining FDA approval for use in both. ...Since its i …
METHODS: A search of Medline for relevant articles on etanercept and psoriasis. RESULTS/CONCLUSION: Etanercept has demonstrate …
Perispinal etanercept stroke trial design: PESTO and beyond.
Tobinick E, Ucci D, Bermudo K, Asseraf S. Tobinick E, et al. Expert Opin Biol Ther. 2024 Oct;24(10):1095-1108. doi: 10.1080/14712598.2024.2390636. Epub 2024 Aug 23. Expert Opin Biol Ther. 2024. PMID: 39177653 Free article. Review.
INTRODUCTION: Perispinal etanercept (PSE) is an innovative treatment designed to improve stroke recovery by addressing chronic post-stroke neuroinflammation. ...The design elements needed to enable a PSE RCT to generate valid results include a suitable research question; a …
INTRODUCTION: Perispinal etanercept (PSE) is an innovative treatment designed to improve stroke recovery by addressing chronic post-s …
Etanercept in the treatment of psoriatic arthritis.
Puig L, López-Ferrer A, Laiz A. Puig L, et al. Actas Dermosifiliogr. 2015 May;106(4):252-9. doi: 10.1016/j.ad.2014.09.004. Epub 2014 Nov 20. Actas Dermosifiliogr. 2015. PMID: 25455504 Free article. Review. English, Spanish.
In clinical trials, etanercept had a safety profile similar to that of placebo and this profile did not change over time. ...Etanercept has a favorable risk-benefit profile in the short term. The concomitant use of methotrexate does not alter etanercept survi …
In clinical trials, etanercept had a safety profile similar to that of placebo and this profile did not change over time. ...Etane …
Etanercept (SB4): A Review in Autoimmune Inflammatory Diseases.
Burness CB, Duggan ST. Burness CB, et al. BioDrugs. 2016 Aug;30(4):371-8. doi: 10.1007/s40259-016-0188-z. BioDrugs. 2016. PMID: 27455991 Review.
Longer-term efficacy (up to 52 weeks) was also similar in both treatment groups. Etanercept (SB4) was generally well tolerated, with a similar safety profile to that of reference etanercept. ...In conclusion, etanercept (SB4) provides therapeutically equivale …
Longer-term efficacy (up to 52 weeks) was also similar in both treatment groups. Etanercept (SB4) was generally well tolerated, with …
Etanercept in axial spondyloarthritis.
Luo G, Zhu J. Luo G, et al. Chin Med J (Engl). 2022 Nov 5;135(21):2628-2630. doi: 10.1097/CM9.0000000000001986. Chin Med J (Engl). 2022. PMID: 35261349 Free PMC article. No abstract available.
Etanercept Prevents Endothelial Dysfunction in Cafeteria Diet-Fed Rats.
Răzvan-Valentin S, Güler SA, Utkan T, Şahin TD, Gacar G, Yazir Y, Rencber SF, Mircea L, Cristian B, Bogdan P, Utkan NZ. Răzvan-Valentin S, et al. Int J Environ Res Public Health. 2022 Feb 14;19(4):2138. doi: 10.3390/ijerph19042138. Int J Environ Res Public Health. 2022. PMID: 35206342 Free PMC article.
Carbachol-induced relaxant responses were impaired in CD-fed rats, while etanercept treatment improved these endothelium-dependent relaxations. No significant change was observed in papaverine- and sodium nitroprusside (SNP)-induced relaxant responses. eNOS expression decr …
Carbachol-induced relaxant responses were impaired in CD-fed rats, while etanercept treatment improved these endothelium-dependent re …
10,361 results
You have reached the last available page of results. Please see the User Guide for more information.